Professor Sanjay Kaul
Cedars-Sinai Medical Centre, Los Angeles (United States of America)
The role of SGLT2 inhibitors in CV risk reduction in patients with type 2 diabetes
Event: ESC Congress 2019
Topic: Diabetes and the Heart
Session: SGLT2 inhibitors in clinical cardiology: modern-day cardiovascular management in patients with type 2 diabetes
ESC 365 is supported by
